The annual general meeting (“AGM”) in Biotec Pharmacon will be held on Thursday 14. May 2020 at 13.00 CET at SIVA Innovation Centre (Linken), Sykehusvegen 23, Tromsø. Due to the Corona pandemic, a number of measures are being taken to prevent the virus from spreading. The measures are implemented to ensure the health and safety of the Company’s employees, shareholders …
Tromsø, 13 December 2019: Biotec Pharmacon (OSE: Biotec) will hold an extraordinary general meeting on Monday 6. January 2020 at 12.30 CET at Hotell Continental, Stortingsgata 24/26, Oslo The primary purpose of the meeting is to elect a new member to the Board of Directors. Please find the notice including agenda for the meeting and appendices attached to this disclosuere. The notice and appendicies will be sent …
Tromsø, Norway, 2nd December 2019 – Biotec Pharmacon (OSE: Biotec) has decided to focus its future on the enzymes business and holds an investor update presentation on 10th December. Seek a new owner for the wound care – Woulgan® Drive profitability through the enzymes business (ArcticZymes) Sales activities in Animal and Consumer health integrated under ArcticZymes. Biotec has for …
(Tromsø/Oslo 23. October 2019) Biotec Pharmacon ASA (OSE: “BIOTEC”) announced today that its Board of Directors has unanimously appointed Dr Jethro Holter as the Company’s interim Chief Executive Officer. Jethro, who currently serves as the Managing Director of ArcticZymes AS, a subsidiary of Biotec Pharmacon, will succeed Christian Jorgensen, the current CEO, effective immediately. Jethro joined ArcticZymes as Managing Director …